Exposing 6 to 8-week-old mice to 2.21% sevoflurane for 4 h might reduce the microbiomes variety in neonatal mice ( What have we learned from recent studies On the one hand, most clinical studies have paid attention to the dose, timing, and frequency of exposure
Documentation of previous weight-loss attempts
& Gasbarrini, A
And when it comes to prescriptions, a 2025 FAIR Health report shows the percentage of overweight or obese adults prescribed a GLP-1 jumped from 0.3 percent in 2019 to 2.05 percent in 2024 an almost 587 percent increase
In patients with AD, an increase in astrocyte-derived circulating exosomes has been observed, which transport proinflammatory cytokines, supporting the idea that reactive astrocytes contribute to inflammation 56
You can read the abstract at Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial Among people who are overweight or obese, it is well established that weight loss can reduce cardiometabolic risk factors